Schaeffer's Top Stock Picks for '25

Biotech Hits Record Low on FDA Curveball

At least two analysts have slashed their price targets on ICPT

Digital Content Manager
May 22, 2023 at 10:53 AM
facebook X logo linkedin


Intercept Pharmaceuticals Inc (NASDAQ: ICPT) stock is down 19.3% at $10.95, after a Food and Drug Administration (FDA) panel voted against recommending accelerated approval for its obeticholic acid treatment for non-alcoholic steatohepatitis (NASH) -- a type of fatty liver disease. The panel referenced data suggesting the benefits of the drug did not outweigh the risks.

Two price-target cuts have already rolled in, with Baird cutting its price objective to $18 from $35, while Wainwright took it down to $8 from $14. Analysts are skeptical on ICPT, with eight calling it a tepid "hold" or worse, while the remaining four rated it a "buy" or better. 

Short sellers are in control, with 3.69 million shares sold short, which account for 9.2% of the equity's available float. It would take nearly one week to buy back these bearish bets, at ICPT's average pace of trading. 

The equity's usually quiet options pits are bursting with activity today. So far, 1,310 calls and 1,344 puts have been traded, which is four times the average intraday volume. Most popular by far is the June 10 put.

The security is fresh off its fourth-straight weekly loss, and earlier gapped to an all-time low of $10.75, guided lower by the 20-day moving average. Shares are also pacing for their biggest single-day percentage drop since June 2020, and have shed more than 45% in the last three months.

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?